An Observational Study to Investigate the Effects of Rapid Transmeridian Travel

Vanda Pharmaceuticals

Status: Completed

Conditions: Jet Lag Disorder

Treatments: Other: Transmeridian travel across multiple time zones

Study type: Observational

Funder types: Industry

Identifiers

NCT02560103

VP-VEC-162-0101

Details and patient eligibility

About

Observational study to investigate circadian rhythm patterns

Enrollment: 119 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Ability and acceptance to provide written consent
• Men or women between 18-75 years
• Body Mass Index of ≥ 18 and ≤ 30 kg/m2

Exclusion criteria

• History (within the 12 months prior to screening) of psychiatric disorders
• Major surgery, trauma, illness or immobile for 3 or more days within the past month
• Pregnancy or recent pregnancy (within 6 weeks)
• A positive test for drugs of abuse at the screening visit
• Any other sound medical reason as determined by the clinical investigator

Trial design

119 participants in 1 patient group

Single group

Description:

No treatment

Treatment:

Other: Transmeridian travel across multiple time zones